Navigation
Trademark Information
Application ID
Status
Date of Application
24 August 2012
Classes
16
Type
Device
State
Maharashtra
Country
Filing Mode
Branch Office
IP Office
MUMBAI
Used Since
01 December 2003
Valid / Upto
24 August 2032
Description
[Class : 16] Printed Materials Consisting Of Drugs And Pharmaceutical Information; Scientific, Surgical And Medical Information
Image (DEVICE)
Documents
| Examination Report |
Uploaded Documents
| 1 | TM-1 | 24 Aug 2012 |
| 10 | TM-R(RENEWAL OF TRADE MARK) | 11 Sep 2021 |
| 11 | TM-M(CERTIFICATIE OF REGISTER (U/S 137) / CERTIFIED COPY OF A DOCUMENT) | 12 Nov 2024 |
| 2 | TM-16 | 12 Sep 2013 |
| 3 | Letter | 13 Nov 2014 |
| 4 | Reply to Exam Report (MIS-R) | 20 Apr 2016 |
| 5 | MIS-A | 21 Apr 2016 |
| 5 | TM-16 | 21 Apr 2016 |
| 6 | MIS-A | 21 Apr 2016 |
| 6 | TM-16 | 21 Apr 2016 |
| 7 | Journal Copy | 22 Feb 2018 |
| 8 | Certificate | 31 Mar 2018 |
| 9 | TM-M(CERTIFICATIE OF REGISTER (U/S 137) / CERTIFIED COPY OF A DOCUMENT) | 18 Apr 2019 |
Correspondence and Notices
| 1 | Dispatching of Examination Report for : 2385028 | 2767305 | 1386734 | 13 Jan 2016 |
| 2 | Abandoned Order for Application No 2385028 | 3323650 | 1700805 | 30 Mar 2016 |
| 3 | Hearing Notice (Show Cause) | 5164315 | 2256736 | 28 Sep 2017 |
| 4 | Tribunal ABA Notice for : 2385028 | 5314018 | 2344158 | 31 Oct 2017 |
| 5 | RENEWAL INTIMATION LETTER | 12149083 | 14 Sep 2021 |
Frequently Asked Questions
What is the application date as per IP India website?
As per IP India data the trademark was applied on 24 August 2012.
Who has filed the trademark application with the TMO?
SUN PHARMA LABORATORIES applied for Sirius.
What is the listed class of the Sirius with IP India?
Listed class of trademark Sirius is 16.
As per IP india what is the stage of trademark application?
Sirius is on the Registered stage of the trademark process.
What is the Serial number provided by the trademark data?
Serial Number provided to trademark application is 2385028
How is the Sirius categorized?
The trademark is categorized as DEVICE.